These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2873870)

  • 1. Is the effect of somatostatin on muscarinic receptors selective to M1 type?
    Miyoshi R; Kito S; Mizuno K; Matsubayashi H
    Brain Res; 1986 Jul; 377(2):348-50. PubMed ID: 2873870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of somatostatin on muscarinic acetylcholine receptor binding in the rat hippocampus.
    Miyoshi R; Kito S; Mizuno K; Matsubayashi H
    Jpn J Pharmacol; 1986 Feb; 40(2):291-6. PubMed ID: 2871210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered muscarinic acetylcholine receptor subtype binding in neonatal rat brain following exposure to chlorpyrifos or methyl parathion.
    Guo-Ross SX; Chambers JE; Meek EC; Carr RL
    Toxicol Sci; 2007 Nov; 100(1):118-27. PubMed ID: 17666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil on the binding characteristics of muscarinic receptor subtypes.
    Baumgold J
    Eur J Pharmacol; 1986 Jul; 126(1-2):151-4. PubMed ID: 3758159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
    Haddad EB; Landry Y; Gies JP
    Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amitriptyline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain.
    Rehavi M; Ramot O; Yavetz B; Sokolovsky M
    Brain Res; 1980 Aug; 194(2):443-53. PubMed ID: 6104533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
    Eva C; Costa E
    J Pharmacol Exp Ther; 1987 Sep; 242(3):888-94. PubMed ID: 2888875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-specific reverse regulation of muscarinic receptors by transition metal ions and guanine nucleotides.
    Gurwitz D; Sokolovsky M
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1296-304. PubMed ID: 7437071
    [No Abstract]   [Full Text] [Related]  

  • 15. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of muscarinic receptors in human, guinea pig and rat lung.
    Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate constants of agonist binding to muscarinic receptors in rat brain medulla. Evaluation by competition kinetics.
    Schreiber G; Henis YI; Sokolovsky M
    J Biol Chem; 1985 Jul; 260(15):8795-802. PubMed ID: 4019454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of muscarinic receptors in rat brain.
    Kuhar MJ; Birdsall NJ; Burgen AS; Hulme EC
    Brain Res; 1980 Feb; 184(2):375-83. PubMed ID: 7353163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.